{
    "clinical_study": {
        "@rank": "112523", 
        "arm_group": {
            "arm_group_label": "Eperisone SR tablet 75mg, Myonal 50mg", 
            "description": "Eperisone SR tablet 75mg Myonal 50mg"
        }, 
        "biospec_descr": {
            "textblock": "plasma"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The purpose of this study is to Evaluate and Compare Safety and Pharmacokinetic of the\n      Eperisone HCl SR and Myonal in healthy Korean male adults."
        }, 
        "brief_title": "Clinical Trial to Compare the Pharmacokinetics and Safety of Eperisone HCl SR Tablet 75mg and Myonal Tablet 50mg", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "Low Back Pain", 
        "condition_browse": {
            "mesh_term": [
                "Back Pain", 
                "Low Back Pain"
            ]
        }, 
        "detailed_description": {
            "textblock": "Myonal: Eperisone Hydrochloride (muscle relaxant)"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy male subjects age between 20 and 55 singed informed consent\n\n        Exclusion Criteria:\n\n          -  Hypotension or hypertension has a history of allergy reaction of this drug or other\n             drugs"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "55 Years", 
            "minimum_age": "20 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "acute low back pain"
            }
        }, 
        "enrollment": {
            "#text": "27", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01775566", 
            "org_study_id": "NVP-EPT-PK-01"
        }, 
        "intervention_browse": {
            "mesh_term": "Eperisone"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 23, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Suwon-si", 
                    "country": "Korea, Republic of", 
                    "state": "Gyeonggi do", 
                    "zip": "441-814"
                }, 
                "name": "Gyeonggi SMB Growth Accelerating Center"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Phase I Clinical Trial to Compare the Pharmacokinetics and Safety of Eperisone HCl SR Tablet 75mg and Myonal Tablet 50mgafter Oral Administration in Healthy Male Subjects.", 
        "overall_official": {
            "affiliation": "Kyungpook National University", 
            "last_name": "Yoon Y Ran, M.D.Ph.D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Auclast, Cmax", 
            "safety_issue": "No", 
            "time_frame": "Eperisone SR 0-24h, Myonal 0-24hr"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01775566"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "AUCinf, Tmax, t1/2, Css,min, Tss,max", 
            "safety_issue": "No", 
            "time_frame": "Eperisone SR 0-24hr, Myonal 0-24hr"
        }, 
        "source": "Navipharm Corporation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Navipharm Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Observational Model: Case-Crossover, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}